A new analysis of Medicare prescription drug plans by the Kaiser Family Foundation doesn’t bode well for the plans.
Kaiser reviewed findings from a series of Medicare Part D Data Spotlights documenting changes in drug coverage and costs since 2006, and found that premiums for prescription drug plans rose, plan availability fell, and most enrollees have a coverage gap, and more. Findings include: